Skip to main content
. 2023 Jan 11;27(1):32–41. doi: 10.4235/agmr.22.0139

Table 1.

PICO criteria

Description
Patient Osteosarcopenia or osteoporosis patients
Intervention Denosumab
Comparator Placebo/other drugs such as zoledronic/bisphosphonate/alendronate
Outcome Changes in lumbar spine BMD, handgrip strength, gait speed, appendicular lean mass, and femoral neck BMD

BMD, bone mineral density.